This webinar will discuss the risks in IV sterile compounding and how to mitigate those risks. We will review the safety requirements in USP <797> and USP <800>, to ensure the safe compounding of CSPs and protection of the patient and compounding staff.
Why Should You Attend
Why Should You Attend
- Do you know the key risk factors when compounding sterile CSPs?
- Do you know the main source of contaminates entering the cleanroom?
- Do you understand regulatory requirements for safe compounding of sterile CSPs?
- Do you know how to protect yourself and your staff from hazardous drug exposure?
- Do you know how to protect the general public from hazardous drug exposure?
This webinar will explain the proper handling of NIOSH listed drugs from receiving to disposal and all handling processes in between: storage, dispensing, compounding.
Learning Objectives
Learning Objectives
- Review the severity of IV compounding errors.
- Review the New ‘proposed’ USP <797> requirements addressing IV compounding safety.
- Review the USP <800> personnel, environment and patient safety requirements.
- Describe the components of IV compounding errors.
- Identify which risk factors and safety issues can be mitigated.
- Discuss how to mitigate risk factors and improve safety of your cleanroom practices and compounded sterile products.
Who Will Benefit:
Pharmacist, Pharmacy Technician, Physician, Nurse, Health Clinic Staff, Retail Pharmacy Staff, Physician Office Staff
Pharmacist, Pharmacy Technician, Physician, Nurse, Health Clinic Staff, Retail Pharmacy Staff, Physician Office Staff
